About 

SBH Sciences is a leading pre-clinical Contract Research Organization (CRO) in the Boston area offering extensive products and services.

ChatGPT Image Jan 14, 2026, 11_23_56 AM-1

Our Mission

To offer superior products and services and provide exemplary customer service, with open communication and on-time delivery. We support entrepreneurial scientists and startups, diagnostic, pharmaceutical, and biotechnology companies with unparalleled experience and expertise that significantly shortens timelines and reduces costs.

 

Our Journey

Founded in 1997 as an entrepreneurial startup focused on mammalian-derived recombinant cytokines, SBH Sciences has evolved into a leading early discovery CRO advancing drug discovery and development. Through our collaborations with over 400 biotechnology and diagnostic companies, we’ve gained profound experience, establishing ourselves as leaders in oncology, immunotherapy, inflammation, and neurodegenerative diseases. With a proven track record in conducting thousands of binding assays and developing over 350 cell-based biological assays, we are globally recognized as the world leader for measuring the biological activity of cytokines and growth factors. Our unique expertise has contributed to the advancement of seven New Chemical Entities (NCEs), five into clinical trials, and one FDA-approved drug.

 

The Global Leader in Cell-Based Assays for Measuring Cytokine Activity

Explore over 350 cell-based assays to measure the biological activity of cytokines, chemokines and growth factors.

Learn More

What We Do and Our Accomplishments

150
Analysis of over 150 biomarkers with expanded multiplex analysis capabilities.		 400+
Multiple cell-based disease models, including over 400 human cancer cell lines.
28 Years
SBH Sciences has provided services to over 300 biotechnology companies globally.		 350+
We offer over 350 cell-based assays for cytokine and chemokine activity.

 

Our Facility

SBH Sciences is located in Natick, MA. We have two state-of-the-art cell culture and protein purification facilities totaling 8,000 ft2 of laboratories and offices, located at 4 Strathmore Road and 27 Strathmore Road. The protein purification labs consist of open-space modules with five large working benches. The cell culture work is separated and conducted in six dedicated cell culture labs. In addition, we have a diagnostics lab, a molecular biology lab, two preparation rooms, six offices and a conference room.

Ventures at SBH

SBH Sciences is excited to expand its offerings and assist entrepreneurs with our new division, Ventures at SBH.

Ventures at SBH aims to incubate breakthrough scientific ideas and to support entrepreneurs in the early stages of research and development. SBH offers extensive lab space, equipment, scientific expertise, business development, grant submission assistance, networking opportunities, and early / seed-stage investments.

Expanding Services

SBH Sciences established two strategic partnerships expanding our services to cover the drug-discovery spectrum from in-vitro lead optimization through innovative animal modeling and companion diagnostics. In addition, SBH has partnered with ABI-LAB, a Boston-based Accelerator and Bio-Incubator, to offer 60 affordable lab spaces as well as innovative pre-clinical services. Find more details in our company presentation.

 

In Memory

SBH Partner & Friend, Eliezer Zomer, PhD.

With great sadness we inform the community of the passing of Eliezer Zomer, z"l, who passed away on February 8th, 2024.
 
Eli, known affectionately as "Eliko," was born in Tel-Aviv in 1946. Eli grew up in the dawn of Israel's independence and embodied the scrappy, adventurous, entrepreneurial spirit of a true sabra - he was a leader in the tzofim (Israeli scouts) and served as a paratrooper who liberated Jerusalem in the 1967 Six-Day War. Eli came to the US where he earned a PhD in Biochemistry.
 
Dr. Zomer was a scientist with over 40 years of proven leadership in biotechnology research, chemical engineering and drug discovery. This includes 30 years of extensive research and development in pharmaceuticals and clinical diagnostics, managing multiple programs for industrial and regulatory applications. Dr. Zomer had vast knowledge of scale-up manufacturing under GMP and GLP, method development, in-vitro diagnostic, validation and regulatory submission. In addition he worked in the development and submission of standard operation and validation protocols for regulatory approval in clinical, veterinary and agrochemical fields. Dr. Zomer was the author of numerous patents and papers on biotech and drug development, and was a Mentor at SBH.
 
We will miss him forever.
zomer